BITD-401412

N/A

Report date: 2023/12/18 18:09:10
NME

Base Information

Drug NameBITD-401412
Drug Alias NameBITD-401412
ClassificationOther
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonists
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsInflammationAutoimmune Diseases of the Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoston Immune Technologies & Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMcQuade Center for Strategic Research and Development LLCOtsuka Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases of the Nervous System
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A